7-1744596-G-A
Variant names:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001128636.4(ELFN1):c.-1G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000236 in 1,511,586 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00024 ( 1 hom. )
Consequence
ELFN1
NM_001128636.4 5_prime_UTR
NM_001128636.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0920
Genes affected
ELFN1 (HGNC:33154): (extracellular leucine rich repeat and fibronectin type III domain containing 1) Predicted to enable protein phosphatase inhibitor activity. Predicted to be involved in synapse organization. Predicted to be located in dendrite and excitatory synapse. Predicted to be active in extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 7-1744596-G-A is Benign according to our data. Variant chr7-1744596-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2657220.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELFN1 | ENST00000424383 | c.-1G>A | 5_prime_UTR_variant | Exon 4 of 4 | 5 | NM_001128636.4 | ENSP00000456548.1 | |||
ELFN1 | ENST00000561626 | c.-1G>A | 5_prime_UTR_variant | Exon 3 of 3 | 2 | ENSP00000457193.1 | ||||
ELFN1 | ENST00000691883 | c.-1G>A | 5_prime_UTR_variant | Exon 3 of 3 | ENSP00000510296.1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152092Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
30
AN:
152092
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000265 AC: 30AN: 113154Hom.: 1 AF XY: 0.000216 AC XY: 13AN XY: 60194
GnomAD3 exomes
AF:
AC:
30
AN:
113154
Hom.:
AF XY:
AC XY:
13
AN XY:
60194
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000241 AC: 327AN: 1359494Hom.: 1 Cov.: 31 AF XY: 0.000254 AC XY: 170AN XY: 668046
GnomAD4 exome
AF:
AC:
327
AN:
1359494
Hom.:
Cov.:
31
AF XY:
AC XY:
170
AN XY:
668046
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000197 AC: 30AN: 152092Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74288
GnomAD4 genome
AF:
AC:
30
AN:
152092
Hom.:
Cov.:
33
AF XY:
AC XY:
13
AN XY:
74288
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Mar 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
ELFN1: BP4, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at